Abstract
Results

101
HIV-associated EVs enhance KSHV infectivity in oral epithelial cells. We treated iSLK-
102
BAC16 cells with sodium butyrate and doxycyline to produce infectious KSHV virions, which dilutions for 24 hr, followed by immunofluorescent staining of cells for KSHV-specific markers.
107
We found that KSHV infected OKF6/TERT2 cells, leading to expression of the KSHV latency- and GFP proteins ( Fig 1A) and flow cytometry on GFP of infected cells (Fig 1B and 1C protein (Fig 3C, arrowheads) and GFP (Fig 3C, arrows) proliferation of cancer cells [26] . HIV+ saliva EVs also contained TAR RNA (Fig 2B) . However, expression of the viral proteins was blocked by cetuximab and AG1478 (Fig 5B) .
214
Cetuximab also blocked HIV+ EV-enhanced KSHV infection in primary oral epithelial cells ( process was blocked by cetuximab and AG1478 (Fig 6A) . Similarly, HIV+ EVs induced 229 phosphorylation of p38 MAPK, but not ERK1/2, in HOECs (Fig 6B) 
Materials and methods
316
Ethical statement
317
For all human subject studies, written informed consent was obtained from all study participants 
Preparation of KSHV virions and EVs
345
EVs were prepared from cell supernatants by differential ultracentrifugation with filtration steps
346
[26]. Briefly, cell culture media were centrifuged at 400 × g for 5 min to remove cells, followed Millipore) for immunoblot analysis. Antibodies used in immunoblotting are listed in S4 Table. 375 Protein detection was performed by chemiluminescence using an ECL kit (ThermoFisher) with 376 the ChemiDoc XRS+ Imaging System (Bio-Rad).
378
Immunofluorescence microscopy 379 Immunofluorescence microscopy of 3-D cultures were performed as previously described [62] 380 with minor modifications. Briefly, each section (5 µm) was de-paraffinized 3 times in Clear-
381
Rite™ 3 and hydrated with 100% Alcohol followed by 95% Alcohol. Samples were blocked 382 with 10% donkey serum at room temperature for 1 hr. Each section was incubated with the 383 primary antibody at 4°C overnight. After washing in PBS, sections were stained with the 384 appropriate AlexaFluor-conjugated secondary antibody to the species of the primary antibody. 20 minutes followed by permeabilization with 0.3% Triton X-100 in PBS. Cells were then 392 stained with the primary antibody followed by incubation with appropriate secondary antibodies.
393
Fluorescent images were taken as described above. Antibodies for immunofluorescence 394 microscopy are listed in S5 Table. 395 396
Statistics
397
Results of treatments were compared with those of respective controls. Data are represented as 398 mean ± S.D. Flow cytometry data were subjected to one-way ANOVA when sample sizes were 399 n ≤ 3. Statistical significance was considered at p< 0.05. For dada with n≤5, F-test was applied.
400
Data analyses were performed and graphs were generated using Prism (GraphPad Software, La 
